Recalled products

Date: 10 May 2023

All unexpired Emerade 500mcg and Emerade 300mcg have been recalled due to suspected drug delivery challenges.

The UK’s medicines regulator, the MHRA (Medicine and Healthcare products Regulatory Agency), has requested the immediate recall of Emerade 500mcg and Emerade 300mcg, two adrenaline pen products. In a recent assessment, the autoinjector devices failed to dispense medicines correctly – either activating too early or completely failing to deliver the adrenaline-based product within them.

All patients who received either of these drug devices since November 2021 must obtain a replacement prescription before returning their Emerade autoinjectors (500mcg and 300mcg) to a pharmacy. New prescriptions can be arranged by speaking with your GP surgery or pharmacy team.

Your pharmacist should provide you with two adrenaline pens from an alternative brand, each with a maximum strength of 300mcg. The brands that your pharmacist may supply include:

• EpiPen
• Jext.

Your pharmacist should explain how your new device works. You should also make sure to read the instructions provided with your new autoinjector prescription.

Both EpiPen and Jext autoinjectors are safe and effective for treating severe allergic reactions (anaphylaxis).

You must remember to carry two autoinjector pens at all times.

The MHRA has issued a letter that provides further advice for patients affected by the recall.

If you have any questions regarding the use of Emerade 500mcg or 300mcg or the risks that these autoinjectors may pose to your health, contact us by emailing hello@well.co.uk  or calling 0333 010 2222. Our phone lines are open Monday to Friday, 8:30 am to 6 pm. Our chat service is also available in our mobile and web app, Monday to Friday 8:30 am to 6 pm, Saturday 8:30 am to 12:30 pm, and Sunday 9 am to 6 pm.

Date: 14 March 2023

Several pholcodine-containing products have been recalled as a precautionary measure by the UK’s medicines regulatory, the MHRA.

Though pholcodine-containing medicines pose a minimal risk to most people. Some data shows, that medicines containing the ingredient, can cause severe, allergic reactions (anaphylaxis), particularly in the 12 months before general anaesthesia.

The list of affected products includes:

• Cofsed Linctus, PL 00240/0097
• Care Pholcodine 5mg/5ml Oral Solution Sugar Free, PL 00240/0101
• Galenphol Linctus, PL 00240/0101
• Galenphol Paediatric Linctus, PL 00240/0102
• Galenphol Strong Linctus, PL 00240/0103
• Covonia Dry Cough Sugar Free Formula, PL 00240/0353
• Pholcodine Linctus Bells Healthcare 5mg Per 5ml Oral Solution, PL 03105/0059
• Numark Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059
• Well Pharmaceuticals Pholcodine 5mg per 5ml Oral Solution, PL 03105/0059
• Strong Pholcodine Linctus BP, PL 03105/0060
• Pholcodine Linctus BP, PL 04917/0002
• Strong Pholcodine Linctus BP, PL 04917/0005
• Pholcodine Linctus, PL 12965/0030
• Day & Night Nurse Capsules, PL 44673/0068
• Day Nurse Capsules, PL 44673/0069
• Day Nurse, PL 44673/0075

Please check the packaging of any dry-cough medicines you are currently using. If pholcodine is listed in the ingredients list on in the patient information leaflet, discontinue its use.

If you are expected to have surgery, you’ll also need to let your doctor know if you have used pholcodine-containing medicines in the last 12 months.

If you have any questions regarding the use of dry-cough medicines or the risks that pholcodine-containing medicines pose to your health contact us by emailing  hello@well.co.uk  or calling  0333 010 2222. Our phone lines are open Monday to Friday, 8:30 am to 6 pm. Our chat service is also available in our mobile and web app, Monday to Friday 8:30 am to 6 pm, Saturday 8:30 am to 12:30 pm, and Sunday 9 am to 6 pm.

Date: June 2021

Co-codamol 30/500 Effervescent Tablets 100s

Zentiva Pharma UK Limited is recalling a specific batch of Co-codamol 30/500 Effervescent Tablets (Pack Size 100 tablets) as a precautionary measure due to an issue with the consistency of the batch.

This specific batch may contain too little medicine or too much medicine. If it contains too much medicine, there is a risk of overdose of paracetamol and the opioid medicine codeine, which can be dangerous. Details of the affected batch are:

BATCH NUMBER (BN): 1K10121

EXPIRY DATE (EXP): 12.2023

Please check if the packaging of your medication matches the details above. This image shows you where to find the batch number and expiry date on the blister pack. If it does, please return it to your local Well pharmacy for a replacement.

If you are an online pharmacy customer (you order your medication using our mobile or web app), please email a photo of your medicine to hello@well.co.uk with the subject “RECALL” and we will arrange for it to be replaced.

You should stop taking this medicine.

Please speak to your GP or a pharmacist if you are suffering from any side effects or feeling unwell since you have been taking these tablets.

If your medicine doesn’t match the affected batch details, you don’t need to do anything. If you’re unsure, please don’t hesitate to contact us.

If you have any questions, please contact us by emailing hello@well.co.uk or calling 0333 010 2222. Our phone lines are open Monday to Friday, 8:30am to 6pm. Our chat service is also available in our mobile and web app, Monday to Friday 8:30am to 6pm, Saturday 8:30am to 12:30pm, and Sunday 9am to 6pm.

Zentiva Pharma UK Limited has issued this letter with further information.